(Q53381487)

13 May 2018

title

Drug prescription in mild cognitive impairment: the physicians' perspective in Italy. (English)

1 reference

13 May 2018

mild cognitive impairment

main subject

Italy

0 references

1 reference

inferred from title

cognitive dysfunction

1 reference

1

1 reference

13 May 2018

Elisa Canu

2

1 reference

13 May 2018

Cristina Geroldi

3

1 reference

13 May 2018

Orazio Zanetti

4

1 reference

13 May 2018

author name string

Valeria Zacchi

5

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 November 2006

1 reference

13 May 2018

International Journal of Geriatric Psychiatry

published in

1 reference

13 May 2018

volume

21

1 reference

13 May 2018

issue

11

1 reference

13 May 2018

page(s)

1071-1077

1 reference

13 May 2018

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

cites work

1 reference

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

21 January 2018

1 reference

Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

21 January 2018

1 reference

Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.

21 January 2018

1 reference

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial

21 January 2018

1 reference

Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.

21 January 2018

1 reference

Long-term acetyl-L-carnitine treatment in Alzheimer's disease

21 January 2018

1 reference

A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.

21 January 2018

1 reference

Survival of Campylobacter jejuni in the presence of bisulfite and different atmospheres

21 January 2018

1 reference

7 January 2021

The predementia diagnosis of Alzheimer disease.

1 reference

7 January 2021

Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study

1 reference

7 January 2021

Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

1 reference

7 January 2021

Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease

1 reference

7 January 2021

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

1 reference

7 January 2021

Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs

1 reference

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

7 January 2021

Current concepts in mild cognitive impairment

1 reference

7 January 2021

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

7 January 2021

Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.

1 reference

7 January 2021

A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease

1 reference

7 January 2021

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

1 reference

7 January 2021

Effect of acetyl-L-carnitine on extracellular amino acid levels in vivo in rat brain regions.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.1609

1 reference

13 May 2018

1 reference

13 May 2018